BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34238154)

  • 1. Lipidomics as Tools for Finding Biomarkers of Intestinal Pathology: From Irritable Bowel Syndrome to Colorectal Cancer.
    Moreno LO; Sánchez PN; Abalo R
    Curr Drug Targets; 2022; 23(6):636-655. PubMed ID: 34238154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in lipidomics: Analytical and clinical perspectives.
    Sethi S; Brietzke E
    Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():8-16. PubMed ID: 28039059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry.
    Zhao YY; Cheng XL; Lin RC
    Int Rev Cell Mol Biol; 2014; 313():1-26. PubMed ID: 25376488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass-spectrometry-based lipidomics.
    Hu T; Zhang JL
    J Sep Sci; 2018 Jan; 41(1):351-372. PubMed ID: 28859259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in lipidomics for disease research.
    Yang L; Li M; Shan Y; Shen S; Bai Y; Liu H
    J Sep Sci; 2016 Jan; 39(1):38-50. PubMed ID: 26394722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel advances in shotgun lipidomics for biology and medicine.
    Wang M; Wang C; Han RH; Han X
    Prog Lipid Res; 2016 Jan; 61():83-108. PubMed ID: 26703190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical lipidomics in the era of the big data.
    Kvasnička A; Najdekr L; Dobešová D; Piskláková B; Ivanovová E; Friedecký D
    Clin Chem Lab Med; 2023 Mar; 61(4):587-598. PubMed ID: 36592414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the metabolomic profiles of irritable bowel syndrome patients with ulcerative colitis patients and healthy controls: new insights into pathophysiology and potential biomarkers.
    Keshteli AH; Madsen KL; Mandal R; Boeckxstaens GE; Bercik P; De Palma G; Reed DE; Wishart D; Vanner S; Dieleman LA
    Aliment Pharmacol Ther; 2019 Mar; 49(6):723-732. PubMed ID: 30706502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics and lipidomics strategies in modern drug discovery and development.
    Astarita G; Kelly RS; Lasky-Su J
    Drug Discov Today; 2023 Oct; 28(10):103751. PubMed ID: 37640150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.
    Sethi S; Hayashi MA; Barbosa BS; Pontes JG; Tasic L; Brietzke E
    Adv Exp Med Biol; 2017; 965():265-290. PubMed ID: 28132184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of Inflammation in Inflammatory Bowel Disease.
    Sands BE
    Gastroenterology; 2015 Oct; 149(5):1275-1285.e2. PubMed ID: 26166315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of G Protein-Coupled Estrogen Receptor in the Pathophysiology of Irritable Bowel Syndrome, Inflammatory Bowel Diseases and Colorectal Cancer.
    Jacenik D; Krajewska WM
    Front Endocrinol (Lausanne); 2020; 11():390. PubMed ID: 32595606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Applications of Lipidomics in Tumor Diagnosis and Therapy.
    Wang Y
    Adv Exp Med Biol; 2021; 1316():25-39. PubMed ID: 33740241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of chemerin in lower gastrointestinal diseases-a review.
    Sochal M; Mosińska P; Fichna J
    Peptides; 2018 Oct; 108():19-24. PubMed ID: 30165089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats.
    Zhao XY; Wang JW; Yin Y; Li K; Zhang M; Yan FP
    World J Gastroenterol; 2019 Sep; 25(34):5134-5151. PubMed ID: 31558862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipidomics in autoimmune diseases with main focus on systemic lupus erythematosus.
    Ferreira HB; Pereira AM; Melo T; Paiva A; Domingues MR
    J Pharm Biomed Anal; 2019 Sep; 174():386-395. PubMed ID: 31207360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical approaches for lipidomics and its potential applications in neuropsychiatric disorders.
    Sethi S; Hayashi MA; Sussulini A; Tasic L; Brietzke E
    World J Biol Psychiatry; 2017 Oct; 18(7):506-520. PubMed ID: 26555297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomics applications for disease biomarker discovery in mammal models.
    Zhao YY; Cheng XL; Lin RC; Wei F
    Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Monitoring of the Mammalian Lipidome by Quantitative Shotgun Lipidomics.
    Nielsen IØ; Maeda K; Bilgin M
    Methods Mol Biol; 2017; 1609():123-139. PubMed ID: 28660579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volatomics in inflammatory bowel disease and irritable bowel syndrome.
    Van Malderen K; De Winter BY; De Man JG; De Schepper HU; Lamote K
    EBioMedicine; 2020 Apr; 54():102725. PubMed ID: 32330874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.